Wu Bingrui, Zhang Shenggao, Zhou Ruihong
Suzhou City Integrated Traditional Chinese and Western Medicine Hospital, Heart Disease Department, Suzhou, China.
J Med Biochem. 2025 Aug 21;44(5):985-993. doi: 10.5937/jomb0-52017.
To explore how Baoyuan and Taohong Siwu decoctions combined with Western medicine affect triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) in elderly patients with coronary heart disease.
Ninety elderly patients with coronary heart disease who were hospitalized from January 2021 to December 2022 were selected and divided into two groups based on different treatment methods, with 45 patients in each group. The control group was treated with Western medicine alone, while the research group was treated with the combination of Baoyuan and Taohong Siwu decoctions based on the control group. The improvement of traditional Chinese medicine symptom scores, various blood lipid levels, and serum indicators of cardiac function were compared between two groups before treatment, 1 month, 2 months, and 3 months of treatment.
Before treatment, the two groups had identical Traditional Chinese Medicine symptom scores, various blood lipid levels, and various serum indicators of cardiac function (P> 0.05). After treating 1 month, 2 months, and 3 months, the chest pain, tightness, fatigue, and sweating scores in the research group were lower (P< 0.05). The TG, TC, LDL-C, and HDL-C levels in the research group were lower (P< 0.05). The levels of plasma N-terminal brain natriuretic peptide (NT-proBNP) and monocyte chemoattractant protein-1 (MCP-1) in the research group were lower (P <0.05).
Combining Baoyuan and Taohong Siwu decoctions and Western medicine treatment can help improve the symptoms and signs of coronary heart disease in the elderly. It can reduce the levels of various indicators such as LDL-C, TG, TC, and HDL-C in the body and promote the improvement of cardiac function.
探讨保元汤合桃红四物汤联合西药对老年冠心病患者甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDL-C)的影响。
选取2021年1月至2022年12月住院的90例老年冠心病患者,根据治疗方法不同分为两组,每组45例。对照组单纯采用西药治疗,研究组在对照组基础上加用保元汤合桃红四物汤治疗。比较两组治疗前、治疗1个月、2个月和3个月时中医症状评分、各项血脂水平及心功能血清指标的改善情况。
治疗前,两组中医症状评分、各项血脂水平及心功能各项血清指标比较,差异无统计学意义(P>0.05)。治疗1个月、2个月和3个月后,研究组胸痛、胸闷、乏力、汗出评分较低(P<0.05)。研究组TG、TC、LDL-C水平较低(P<0.05),HDL-C水平较高(P<0.05)。研究组血浆N末端脑钠肽前体(NT-proBNP)和单核细胞趋化蛋白1(MCP-1)水平较低(P<0.05)。
保元汤合桃红四物汤联合西药治疗有助于改善老年冠心病患者的症状体征,降低体内LDL-C、TG、TC等各项指标水平,促进心功能改善。